Mo. Attorney General sends prescription manufacturer Eli Lilly cease-and-desist over drug price policy
Missouri Attorney General Catherine Hanaway issued a cease-and-desist letter to drug manufacturer Eli Lilly, demanding the company halt its policy of requiring extensive claims data from hospitals seeking 340B drug discounts. Hanaway gave Eli Lilly until November 26 to comply, warning that the pricing conditions violate state law and harm eligible healthcare providers. The action follows a pricing dispute involving MU Health Care, and mirrors broader legal challenges from major hospital systems including MGH and Brigham, which have sued Eli Lilly over similar drug discount practices.
Listen to Live Briefing
Real-time synthesized voice briefing · Live Feeds Desk
- ✓ Missouri Attorney General Catherine Hanaway sent a cease-and-desist letter to drug manufacturer Eli Lilly.
- ✓ The Attorney General ordered Eli Lilly to stop requiring extensive data from hospitals seeking 340B drug discounts.
- ✓ Eli Lilly was given until November 26 to comply with the state order.
- ✓ Hospitals including MGH and Brigham have also sued Eli Lilly over drug discount programs.
What changed
Missouri Attorney General Catherine Hanaway officially entered the 340B dispute by issuing a cease-and-desist letter with a strict compliance deadline.
Live updates
-
Mo. AG Orders Eli Lilly to Halt 340B Data Policy
Missouri Attorney General Catherine Hanaway issued a cease-and-desist letter to drug manufacturer Eli Lilly, demanding the company halt its policy of requiring extensive claims data from hospitals seeking 340B drug discounts. Hanaway gave Eli Lilly until November 26 to comply, warning that the pricing conditions violate state law and harm eligible healthcare providers. The action follows a pricing dispute involving MU Health Care, and mirrors broader legal challenges from major hospital systems including MGH and Brigham, which have sued Eli Lilly over similar drug discount practices.
Why it matters
The 340B federal drug pricing program allows qualifying hospitals to purchase outpatient drugs at discounted rates to serve low-income patients. Pharmaceutical manufacturers have increasingly pushed back against the program by imposing restrictive data-sharing mandates on participating healthcare providers. These ongoing disputes have escalated into state-level interventions and multi-hospital lawsuits alleging coercive practices by drug makers.
What is confirmed
- Missouri Attorney General Catherine Hanaway sent a cease-and-desist letter to drug manufacturer Eli Lilly.
- The Attorney General ordered Eli Lilly to stop requiring extensive data from hospitals seeking 340B drug discounts.
- Eli Lilly was given until November 26 to comply with the state order.
- Hospitals including MGH and Brigham have also sued Eli Lilly over drug discount programs.
What to watch next
- Whether Eli Lilly complies with the November 26 deadline set by the Missouri Attorney General
- Potential legal challenges or responses from Eli Lilly regarding the Missouri cease-and-desist order
confidence 100%Sources used for this update (9)
- KMOV — Mo. Attorney General sends prescription manufacturer Eli Lilly cease-and-desist over drug price policy
- The Boston Globe — MGH, Brigham, other hospitals sue Eli Lilly, alleging ‘extortion’ in drug discount program
- KOMU 8 — Missouri Attorney General sends cease-and-desist letter to drug manufacturer
- ABC17NEWS — AG sends cease-and-desist letter to pharmaceutical company after pricing spat with MU Health Care
- STAT — Missouri AG warns Lilly to stop requiring data from hospitals seeking 340B drug discounts
- www.firstalert4.com — Mo. Attorney General sends prescription manufacturer Eli ...
- www.kctv5.com — Missouri AG orders pharmaceutical company to stop unlawful ...
- www.komu.com — Missouri AG sends cease-and-desist to drug manufacturer ...
- www.medicaldaily.com — Missouri Attorney General Gives Eli Lilly Until November 26 ...
Community Sentiment: How do you assess this situation?
Voice your perspective · Real-time aggregated sentiment from the Live Feeds community